Associated Papers
A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes.
Rayan MN et al.
Immunity, Inflammation and Disease, 2026
Controlled WASp activity regulates the proliferative response for Treg cell differentiation in the thymus.
Vasconcelos-Fontes L et al.
European Journal of Immunology, 2024
Understanding immunoactinopathies: A decade of research on WAS gene defects.
Vieira RC et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, 2023
A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome.
Marx D et al.
Blood Advances, 2022
The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective.
Ikeda M et al.
Biochemical and Biophysical Research Communications, 2022
Overactive WASp in X-linked neutropenia leads to aberrant B-cell division and accelerated plasma cell generation.
He M et al.
The Journal of Allergy and Clinical Immunology, 2022
Constitutive activation of WASp leads to abnormal cytotoxic cells with increased granzyme B and degranulation response to target cells.
Kritikou JS et al.
Jci Insight, 2021
[X-linked neutropenia caused by gain-of-function mutation in WAS gene: two cases report and literature review].
Xia Y et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics, 2019
A novel mutation in Wiskott-Aldrich gene manifesting as macrothrombocytopenia and neutropenia.
Arwani M et al.
Bmj Case Reports, 2018
Phenotype-based gene analysis allowed successful diagnosis of X-linked neutropenia associated with a novel WASp mutation.
Kobayashi M et al.
Annals of Hematology, 2018
Whole Exome Sequencing of an X-linked Thrombocytopenia Patient with Normal Sized Platelets.
Fathi M et al.
Avicenna Journal of Medical Biotechnology, 0
Select a paper to view details